时间标签：数据日期 2026-11-03 · 生成时间 2026-11-03 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/10/31 – 2026/11/03 ｜ 情报发生日期 2026-11-03
证据级别：摘要级。本条依据 PubMed 结构化摘要与元数据撰写，付费墙全文未获取、未逐节核验，本站未做任何数值推算补全。
摘要（PubMed 原文节选）
The gut microbiome may be involved in bone health through the gut-bone axis. Saccharomyces cerevisiae CNCM I-3856 benefits gut health in patients with irritable bowel syndrome, which is more prevalent in women and may be associated with higher osteoporosis prevalence. We evaluated the effects of S. cerevisiae CNCM I-3856 ± vitamin K2 (K2) on the gut microbiota of patients with osteoporosis and healthy controls. Short-term in vitro colonic fermentations were performed using feces from healthy and osteoporosis-diagnosed individuals (n = 12/cohort). Three conditions were tested: untreated, probiotic, probiotic+K2. Colonic supernatants (48 h) were evaluated for microbial metabolic and community …
对本项目的价值
参考价值：属「微生物组—宿主老化界面」方向；肌肉骨骼 / 衰弱 / 肌少症栏目可用作本项目文献库与综述素材。 ｜ 价值分 1.7/5（★★☆☆☆）
全文不可及原因
标注 OA 但 PDF 下载失败或未通过题名指纹归属校验
原文题录
- 中文题名：酿酒酵母 CNCM I-3856 与维生素 K2 对骨质疏松患者肠道菌群的影响
- 英文标题：Effects of Saccharomyces cerevisiae CNCM I-3856 and vitamin K2 on the gut microbiota of patients with osteoporosis and healthy controls using in vitro short-term colonic simulations.
- 期刊与标识：Food Res Int · PMID 42967716 · DOI 10.1016/j.foodres.2026.120894 · EDAT 2026-11-01